BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 32115315)

  • 1. You say "schizophrenia" and I say "psychosis": Just tell me when I can come off this medication.
    Zipursky RB; Odejayi G; Agid O; Remington G
    Schizophr Res; 2020 Nov; 225():39-46. PubMed ID: 32115315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of symptom recurrence with medication discontinuation in first-episode psychosis: a systematic review.
    Zipursky RB; Menezes NM; Streiner DL
    Schizophr Res; 2014 Feb; 152(2-3):408-14. PubMed ID: 23972821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcome after antipsychotic treatment discontinuation in functionally recovered first-episode nonaffective psychosis individuals: a 3-year naturalistic follow-up study.
    Mayoral-van Son J; de la Foz VO; Martinez-Garcia O; Moreno T; Parrilla-Escobar M; Valdizan EM; Crespo-Facorro B
    J Clin Psychiatry; 2016 Apr; 77(4):492-500. PubMed ID: 26759992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond Clinical Remission in First Episode Psychosis: Thoughts on Antipsychotic Maintenance vs. Guided Discontinuation in the Functional Recovery Era.
    Alvarez-Jimenez M; O'Donoghue B; Thompson A; Gleeson JF; Bendall S; Gonzalez-Blanch C; Killackey E; Wunderink L; McGorry PD
    CNS Drugs; 2016 May; 30(5):357-68. PubMed ID: 27106296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial.
    Begemann MJH; Thompson IA; Veling W; Gangadin SS; Geraets CNW; van 't Hag E; Müller-Kuperus SJ; Oomen PP; Voppel AE; van der Gaag M; Kikkert MJ; Van Os J; Smit HFE; Knegtering RH; Wiersma S; Stouten LH; Gijsman HJ; Wunderink L; Staring ABP; Veerman SRT; Mahabir AGS; Kurkamp J; Pijnenborg GHM; Veen ND; Marcelis M; Grootens KP; Faber G; van Beveren NJ; Been A; van den Brink T; Bak M; van Amelsvoort TAMJ; Ruissen A; Blanke C; Groen K; de Haan L; Sommer IEC
    Trials; 2020 Feb; 21(1):147. PubMed ID: 32033579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effects of discontinuation from antipsychotic maintenance following first-episode schizophrenia and related disorders: a 10 year follow-up of a randomised, double-blind trial.
    Hui CLM; Honer WG; Lee EHM; Chang WC; Chan SKW; Chen ESM; Pang EPF; Lui SSY; Chung DWS; Yeung WS; Ng RMK; Lo WTL; Jones PB; Sham P; Chen EYH
    Lancet Psychiatry; 2018 May; 5(5):432-442. PubMed ID: 29551618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rates and predictors of relapse following discontinuation of antipsychotic medication after a first episode of psychosis.
    Bowtell M; Eaton S; Thien K; Bardell-Williams M; Downey L; Ratheesh A; Killackey E; McGorry P; O'Donoghue B
    Schizophr Res; 2018 May; 195():231-236. PubMed ID: 29066258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evaluation and treatment of first-episode psychosis.
    Sheitman BB; Lee H; Strous R; Lieberman JA
    Schizophr Bull; 1997; 23(4):653-61. PubMed ID: 9366001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and demographic predictors of continuing remission or relapse following discontinuation of antipsychotic medication after a first episode of psychosis. A systematic review.
    Bowtell M; Ratheesh A; McGorry P; Killackey E; O'Donoghue B
    Schizophr Res; 2018 Jul; 197():9-18. PubMed ID: 29146020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guidelines for Discontinuation of Antipsychotics in Patients Who Recover From First-Episode Schizophrenia Spectrum Disorders: Derived From the Aggregated Opinions of Asian Network of Early Psychosis Experts and Literature Review.
    Asian Network of Early Psychosis Writing Group
    Int J Neuropsychopharmacol; 2022 Sep; 25(9):737-758. PubMed ID: 35451023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trajectories after first-episode psychosis: Complement to ambiguous outcomes of long-term antipsychotic treatment by exploring a few hidden cases.
    Liu CC; Lin YT; Liu CM; Hsieh MH; Chien YL; Hwang TJ; Hwu HG
    Early Interv Psychiatry; 2019 Aug; 13(4):895-901. PubMed ID: 29927087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of discontinuation v. maintenance of antipsychotic medication on relapse rates in patients with remitted/stable first-episode psychosis: a meta-analysis.
    Kishi T; Ikuta T; Matsui Y; Inada K; Matsuda Y; Mishima K; Iwata N
    Psychol Med; 2019 Apr; 49(5):772-779. PubMed ID: 29909790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsychotic Medication Continuation vs Taper and Discontinuation in Patients With Schizophrenia and Other Nonaffective Psychotic Disorders.
    Andrade C
    J Clin Psychiatry; 2024 May; 85(2):. PubMed ID: 38767930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TAILOR - tapered discontinuation versus maintenance therapy of antipsychotic medication in patients with newly diagnosed schizophrenia or persistent delusional disorder in remission of psychotic symptoms: study protocol for a randomized clinical trial.
    Stürup AE; Jensen HD; Dolmer S; Birk M; Albert N; Nielsen M; Hjorthøj C; Eplov L; Ebdrup BH; Mors O; Nordentoft M
    Trials; 2017 Sep; 18(1):445. PubMed ID: 28962668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals.
    Velakoulis D; Wood SJ; Wong MT; McGorry PD; Yung A; Phillips L; Smith D; Brewer W; Proffitt T; Desmond P; Pantelis C
    Arch Gen Psychiatry; 2006 Feb; 63(2):139-49. PubMed ID: 16461856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antipsychotic medication and remission of psychotic symptoms 10years after a first-episode psychosis.
    Wils RS; Gotfredsen DR; Hjorthøj C; Austin SF; Albert N; Secher RG; Thorup AA; Mors O; Nordentoft M
    Schizophr Res; 2017 Apr; 182():42-48. PubMed ID: 28277310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poor medication adherence and risk of relapse associated with continued cannabis use in patients with first-episode psychosis: a prospective analysis.
    Schoeler T; Petros N; Di Forti M; Klamerus E; Foglia E; Murray R; Bhattacharyya S
    Lancet Psychiatry; 2017 Aug; 4(8):627-633. PubMed ID: 28705600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relapse rates following antipsychotic discontinuation in the maintenance phase after first-episode of schizophrenia: Results of a long-term follow-up study.
    Üçok A; Kara İA
    Schizophr Res; 2020 Nov; 225():31-38. PubMed ID: 31653578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perceptions of relapse risks following first-episode psychosis and attitudes towards maintenance medication: a comparison between nursing and social work professionals.
    Chan KK; Chin QP; Tang JY; Longenecker J; Hui CL; Chiu CP; Lam MM; Wong GH; Chen EY
    Early Interv Psychiatry; 2011 Nov; 5(4):324-34. PubMed ID: 21521490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guided discontinuation versus maintenance treatment in remitted first-episode psychosis: relapse rates and functional outcome.
    Wunderink L; Nienhuis FJ; Sytema S; Slooff CJ; Knegtering R; Wiersma D
    J Clin Psychiatry; 2007 May; 68(5):654-61. PubMed ID: 17503973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.